Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Trends Cancer. 2022 Feb 3;8(5):404–415. doi: 10.1016/j.trecan.2022.01.008

Figure 2, Key Figure. Transcriptional mechanisms that drive response and resistance to cancer immunotherapies.

Figure 2, Key Figure.

Schematic depicting the role of transcription profile changes, DNA methylation changes, and changes in transcription factor and chromatin regulators on immune cell function and the immunotherapeutic response.